117 related articles for article (PubMed ID: 25889623)
1. Identification of regulatory SNPs associated with genetic modifications in lung adenocarcinoma.
Lu TP; Hsiao CK; Lai LC; Tsai MH; Hsu CP; Lee JM; Chuang EY
BMC Res Notes; 2015 Mar; 8():92. PubMed ID: 25889623
[TBL] [Abstract][Full Text] [Related]
2. Screening of lung cancer related SNPs and CNVs with SNP microarrays.
Li TY; Zhang F
Eur Rev Med Pharmacol Sci; 2015; 19(2):225-34. PubMed ID: 25683935
[TBL] [Abstract][Full Text] [Related]
3. SNP rs10248565 in HDAC9 as a novel genomic aberration biomarker of lung adenocarcinoma in non-smoking women.
Lai LC; Tsai MH; Chen PC; Chen LH; Hsiao JH; Chen SK; Lu TP; Lee JM; Hsu CP; Hsiao CK; Chuang EY
J Biomed Sci; 2014 Mar; 21(1):24. PubMed ID: 24650256
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients.
Son JW; Jeong KJ; Jean WS; Park SY; Jheon S; Cho HM; Park CG; Lee HY; Kang J
Cancer Lett; 2011 Dec; 311(1):29-37. PubMed ID: 21757291
[TBL] [Abstract][Full Text] [Related]
5. Identification of genome variations in patients with lung adenocarcinoma using whole genome re‑sequencing.
Li G; Mei Y; Yang F; Yi S; Wang L
Mol Med Rep; 2017 Dec; 16(6):9464-9472. PubMed ID: 29039585
[TBL] [Abstract][Full Text] [Related]
6. Integrated analyses of copy number variations and gene expression in lung adenocarcinoma.
Lu TP; Lai LC; Tsai MH; Chen PC; Hsu CP; Lee JM; Hsiao CK; Chuang EY
PLoS One; 2011; 6(9):e24829. PubMed ID: 21935476
[TBL] [Abstract][Full Text] [Related]
7. The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer.
Chen JT; Cheng YW; Chou MC; Sen-Lin T; Lai WW; Ho WL; Lee H
Clin Cancer Res; 2003 Sep; 9(11):4200-4. PubMed ID: 14519646
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide single nucleotide polymorphism analysis of lung cancer risk detects the KLF6 gene.
Spinola M; Leoni VP; Galvan A; Korsching E; Conti B; Pastorino U; Ravagnani F; Columbano A; Skaug V; Haugen A; Dragani TA
Cancer Lett; 2007 Jun; 251(2):311-6. PubMed ID: 17223258
[TBL] [Abstract][Full Text] [Related]
9. Nonsynonymous single nucleotide polymorphisms in DNA damage repair pathways and lung cancer risk.
Tanaka Y; Maniwa Y; Bermudez VP; Doi T; Nishio W; Ohbayashi C; Okita Y; Hurwitz J; Hayashi Y; Yoshimura M
Cancer; 2010 Feb; 116(4):896-902. PubMed ID: 20052722
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma.
Goto Y; Shinjo K; Kondo Y; Shen L; Toyota M; Suzuki H; Gao W; An B; Fujii M; Murakami H; Osada H; Taniguchi T; Usami N; Kondo M; Hasegawa Y; Shimokata K; Matsuo K; Hida T; Fujimoto N; Kishimoto T; Issa JP; Sekido Y
Cancer Res; 2009 Dec; 69(23):9073-82. PubMed ID: 19887624
[TBL] [Abstract][Full Text] [Related]
11. Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers.
Toyooka S; Tokumo M; Shigematsu H; Matsuo K; Asano H; Tomii K; Ichihara S; Suzuki M; Aoe M; Date H; Gazdar AF; Shimizu N
Cancer Res; 2006 Feb; 66(3):1371-5. PubMed ID: 16452191
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.
Lee Y; Yoon KA; Joo J; Lee D; Bae K; Han JY; Lee JS
Carcinogenesis; 2013 Feb; 34(2):307-13. PubMed ID: 23144319
[TBL] [Abstract][Full Text] [Related]
13. Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung.
Tsou JA; Shen LY; Siegmund KD; Long TI; Laird PW; Seneviratne CK; Koss MN; Pass HI; Hagen JA; Laird-Offringa IA
Lung Cancer; 2005 Feb; 47(2):193-204. PubMed ID: 15639718
[TBL] [Abstract][Full Text] [Related]
14. Tagging single nucleotide polymorphisms in MBD4 are associated with risk of lung cancer in a Chinese population.
Miao R; Gu H; Liu H; Hu Z; Jin G; Wang H; Wang Y; Sun W; Ma H; Chen D; Tian T; Jin L; Wei Q; Lu D; Huang W; Shen H
Lung Cancer; 2008 Dec; 62(3):281-6. PubMed ID: 18495292
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
Zhong S; Fields CR; Su N; Pan YX; Robertson KD
Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
[TBL] [Abstract][Full Text] [Related]
16. Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: its association with clinicopathologic features.
Shibata T; Uryu S; Kokubu A; Hosoda F; Ohki M; Sakiyama T; Matsuno Y; Tsuchiya R; Kanai Y; Kondo T; Imoto I; Inazawa J; Hirohashi S
Clin Cancer Res; 2005 Sep; 11(17):6177-85. PubMed ID: 16144918
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation markers of surfactant proteins in lung cancer.
Lin Z; Thomas NJ; Bibikova M; Seifart C; Wang Y; Guo X; Wang G; Vollmer E; Goldmann T; Garcia EW; Zhou L; Fan JB; Floros J
Int J Oncol; 2007 Jul; 31(1):181-91. PubMed ID: 17549420
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide association study in discordant sibships identifies multiple inherited susceptibility alleles linked to lung cancer.
Galvan A; Falvella FS; Frullanti E; Spinola M; Incarbone M; Nosotti M; Santambrogio L; Conti B; Pastorino U; Gonzalez-Neira A; Dragani TA
Carcinogenesis; 2010 Mar; 31(3):462-5. PubMed ID: 20022890
[TBL] [Abstract][Full Text] [Related]
19. Loss of function of p16 gene and prognosis of pulmonary adenocarcinoma.
Tanaka R; Wang D; Morishita Y; Inadome Y; Minami Y; Iijima T; Fukai S; Goya T; Noguchi M
Cancer; 2005 Feb; 103(3):608-15. PubMed ID: 15612080
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylation of the GATA genes in lung cancer.
Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV
Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
